Live Quote · NASDAQRGNXHealthcare· Biotechnology

REGENXBIO Inc.

$7.16▼ 0.28%($-0.02)
MKT CAP $473.44MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
64/100
▌ Mixed
70
Valuation
40
Profitability
95
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RGNX research report →

Analyst Price Target
$20.80+190.5% vs. today

Range $18 – $29

Analyst RatingBuy
13 Buy6 Hold1 Sell

Price Chart

-34.13% · this period
$15.98$10.82$5.65Nov 20May 26Nov 20
52-Week Range16% of range
Low
$5.46
Current
$7.16
High
$16.19